BridgeMD
New treatment option for Hiv
Official title Finishing HIV Project
ClinicalTrials.gov ID: NCT06406049
What this study is testing
- What it's testing
- This study aims to learn how to help enable healthy behaviors and lower the risk of HIV among Latinx Men.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 54, men only. Healthy volunteers may be eligible.
You may be able to join if
- Provision of signed and dated informed consent form
- Stated willingness to comply with all study procedures and availability for the duration of the study
- Being 18 to 54 years of age
- Being a cis-gender male
- Self-report one or more of the following behaviors and health conditions in the last 6 months which meet the Centers for Disease Control and...
You likely can't join if
- Display diminished capacity to consent because of:
- An inability to provide informed consent (e.g., cognitive impairment)
- Severe psychiatric symptoms (e.g., mania, psychosis) that impair capacity to provide informed consent, as assessed by interviewers with Collaborative...
- \ 54 years old
- Self-reported living with HIV
- Reactive HIV test (for "Amigx" seeds or "Yo Quiero" control participants)
See the full eligibility criteria
- Provision of signed and dated informed consent form
- Stated willingness to comply with all study procedures and availability for the duration of the study
- Being 18 to 54 years of age
- Being a cis-gender male
- Self-report one or more of the following behaviors and health conditions in the last 6 months which meet the Centers for Disease Control and Prevention (CDC) clinical guidelines for PrEP eligibility
- Diagnosed with bacterial sexually transmitted infection (e.g., syphilis, gonorrhea, or chlamydia)
- Sex with a partner who is living with HIV
- Sex without a condom with two or more partners whose HIV status were unknown
- Injection drug use and sharing injection equipment
- Self-reported status as HIV negative
- Willing to be tested for HIV
- Display diminished capacity to consent because of:
- An inability to provide informed consent (e.g., cognitive impairment)
- Severe psychiatric symptoms (e.g., mania, psychosis) that impair capacity to provide informed consent, as assessed by interviewers with Collaborative Institutional Training Initiative (CITI) Human people Research and...
- \ 54 years old
- Self-reported living with HIV
- Reactive HIV test (for "Amigx" seeds or "Yo Quiero" control participants)
- Refusal of HIV test
- Identifies as Non-Latinx
- Individuals enrolled in other PrEP initiation interventions
- Individuals with an active PrEP prescription in the last 6-months (oral or injectable)
The study team makes the final eligibility decision.
Where it's taking place
- Miami, Florida, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 18 years to 54 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Miami, Florida, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.